col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


123 Results       Page 1

 [1] 
Oxford University Press: Inflammatory Bowel Diseases
  original article Date Title Authors   All Authors
1 [GO] 2024―Jan―25 THE BURDEN OF INFLAMMATORY BOWEL DISEASE ON COVID-19 HOSPITALIZATIONS: A NATIONWIDE ANALYSIS Humzah Iqbal, Rakahn Haddadin, Hasib Haidary, Patrick Zhang, Devang Prajapati
2 [GO] 2024―Jan―25 EXPLORING FACTORS ASSOCIATED WITH SEROLOGICAL RESPONSE TO SARS-COV-2 VACCINES IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE: INTERACTIVE VISUALIZATION METHODS FOR MULTIDIMENSIONAL DATA Lindsay Hracs, Joshua Quan, Christopher Ma, Remo Panaccione, Nastaran Sharifi, Michelle Herauf, et al. (+13)
3 [GO] 2023―Sep―29 Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease Yoo Jin Lee, Dalin Li, Angela Mujukian, Philip Debbas, Melissa Hampton, Emebet Mengesha, et al. (+72)
4 [GO] 2023―Sep―19 Predictors of Hospital-related Outcomes of COVID-19 Infection in Patients With Inflammatory Bowel Disease in the Early Pandemic Phase: A Nationwide Inpatient Database Survey Khadija Naseem, Abdullah Sohail, Vu Quang Nguyen, Ahmad Khan, Gregory Cooper, Bret Lashner, et al. (+4)
5 [GO] 2023―Aug―05 Corticosteroids but not Anti-TNF Are Associated With Increased COVID-19 Complications in Patients With Inflammatory Bowel Disease Millie D Long, Lauren Parlett, James D Lewis, Kevin Haynes, Sruthi Adimadhyam, Laura Hou, et al. (+5)
6 [GO] 2023―Aug―04 Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study Aakash Desai, Aakriti Soni, Mary S Hayney, Jana G Hashash, Gursimran S Kochhar, Francis A Farraye, Freddy Caldera
7 [GO] 2023―Jun―30 Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study Fabio Salvatore Macaluso, Mariabeatrice Principi, Federica Facciotti, Antonella Contaldo, Alessia Todeschini, Simone Saibeni, et al. (+41)
8 [GO] 2023―Jun―25 Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium Serre-Yu Wong, Judith Wellens, Drew Helmus, Luke Marlow, Stephanie Brann, Vicky Martinez Pazos, et al. (+80)
9 [GO] 2023―Jun―07 Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study Angela Mujukian, Rashmi Kumar, Dalin Li, Philip Debbas, Gregory J Botwin, Susan Cheng, et al. (+53)
10 [GO] 2023―Apr―18 Additional COVID-19 Booster Doses Increase Anti-spike Serum Antibody Concentrations Among Patients With Inflammatory Bowel Disease Trevor L Schell, Oscar Ramirez, Mazen Almasry, Francis A Farraye, Mary S Hayney, Freddy Caldera
11 [GO] 2023―Apr―17 COVID-19 Does Not Lead to an Increase in Corticosteroid Prescriptions in IBD Patients: A Nationwide Cohort Study Bente Mertz Nørgård, Floor Dijkstra Zegers, Jan Nielsen, Torben Knudsen, Jens Kjeldsen
12 [GO] 2023―Mar―31 Long-Term Impact of the COVID-19 Pandemic on Inflammatory Bowel Disease Healthcare Utilization: A 2-Year Nationwide Update Monica E W Derks, Lisa M A van Lierop, Maarten te Groen, Chantal C H J Kuijpers, Iris D Nagtegaal, Frank Hoentjen
13 [GO] 2023―Mar―21 Assessing the Impact of COVID-19 on IBD Outcomes Among Vulnerable Patient Populations in a Large Metropolitan Center Florence-Damilola Odufalu, Justin L Sewell, Vivek Rudrapatna, Ma Somsouk, Uma Mahadevan
14 [GO] 2023―Feb―15 Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease Freddy Caldera, Luke Richard, Mazen Almasry, Hiep Phan, Kelly Chun, Francis A Farraye, Mary S Hayney
15 [GO] 2023―Jan―30 Reply to “Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination” Hiep Phan, Mary S Hayney, Freddy Caldera
16 [GO] 2022―Dec―29 Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination: Correspondence Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
17 [GO] 2022―Dec―28 Effect of 2 vs 3 Doses of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease: A Population-based Propensity Matched Analysis Aakash Desai, Parakkal Deepak, Raymond K Cross, Julie Murone, Francis A Farraye, Ryan C Ungaro, Gursimran S Kochhar
18 [GO] 2022―Nov―02 Impact of Biologic Agents on the Immune Response Induced by the Additional Dose of SARS-CoV-2 Vaccine in Inflammatory Bowel Disease Patients Laura Ramos, Miriam Hernández-Porto, Marta Carrillo-Palau, Inmaculada Alonso-Abreu, Cristina Reygosa, Manuel Hernandez-Guerra
19 [GO] 2022―Sep―14 Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination Freddy Caldera, Francis A Farraye, Brian M Necela, Davitte Cogen, Sumona Saha, Arnold Wald, et al. (+13)
20 [GO] 2022―Sep―13 Humoral Immunogenicity After Vaccination Against SARS-CoV-2 Infection in Inflammatory Bowel Disease Patients Under Immunosuppressive Therapy: Should We Prioritize an Additional Booster Injection? Vítor Macedo Silva, Tiago Lima Capela, Marta Freitas, Tiago Cúrdia Gonçalves, Pedro Boal Carvalho, Francisca Dias de Castro, et al. (+2)
21 [GO] 2022―Aug―23 Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD Dalin Li, Philip Debbas, Angela Mujukian, Susan Cheng, Jonathan Braun, Dermot P B McGovern, et al. (+66)
22 [GO] 2022―Aug―16 IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame Cristina Bezzio, Gionata Fiorino, Davide G Ribaldone, Alessandro Armuzzi, Simone Saibeni, Marta Vernero, et al. (+35)
23 [GO] 2022―Jul―13 Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease Kimberly N Weaver, Xian Zhang, Xiangfeng Dai, Wenli Chen, Runa Watkins, Jeremy Adler, et al. (+17)
24 [GO] 2022―Jun―28 De Novo Pediatric Ulcerative Colitis Triggered by SARS-CoV-2 Infection: a Tale of 2 Sisters Nicholas A Preziosi, Areeba H Rizvi, John D Feerick, Chetan Mandelia
25 [GO] 2022―Jun―06 Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: A Survey From China Wen-ning Tian, Yu-hong Huang, Cong Dai
26 [GO] 2022―May―31 Correspondence on “Immunogenicity of COVID-19 Vaccine Doses in Patients With Inflammatory Bowel Disease” Pathum Sookaromdee, Viroj Wiwanitkit
27 [GO] 2022―Apr―09 Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease Trevor L Schell, Keith L Knutson, Sumona Saha, Arnold Wald, Hiep S Phan, Mazen Almasry, et al. (+6)
28 [GO] 2022―Apr―09 Prevalence of SARS-COV-2 Vaccination and Factors Impacting Likelihood of Vaccination in a Nationwide Veterans Affairs Cohort of IBD Patients Nadim Mahmud, Yash Shah, Nabeel Khan
29 [GO] 2022―Apr―09 The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy Dalin Li, Alexander Xu, Emebet Mengesha, Rebecca Elyanow, Rachel M Gittelman, Heidi Chapman, et al. (+18)
30 [GO] 2022―Apr―08 Reply to Response to “‘A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses After COVID-19 Vaccination’” by Mungmunpuntipantip and Wiwanitkiton Yasuhiro Masuta, Tomohiro Watanabe, Kosuke Minaga, Masatoshi Kudo
31 [GO] 2022―Apr―08 Ulcerative Colitis Relapse After COVID-19 Vaccination: Correspondence Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
32 [GO] 2022―Apr―06 Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19 Fabio Salvatore Macaluso, Alessandra Giuliano, Walter Fries,, Anna Viola, Alfredo Abbruzzese, et al. (+20)
33 [GO] 2022―Apr―01 Response to: COVID-19 Vaccination, Willingness, Hesitancy, and Inflammatory Bowel Diseases Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
34 [GO] 2022―Mar―25 Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based Study Mohamed Attauabi, Jens Frederik Dahlerup, Anja Poulsen, Malte Rosager Hansen, Marianne Kajbæk Vester-Andersen, August Pilegaard Prahm, et al. (+14)
35 [GO] 2022―Mar―03 Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry Emily Spiera, Danielle Y Ganjian, Xian Zhang, Erica J Brenner, Manasi Agrawal, Jean-Frederic Colombel, et al. (+3)
36 [GO] 2022―Feb―26 A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses after COVID-19 Vaccination Yasuhiro Masuta, Tomohiro Watanabe, Kosuke Minaga, Masatoshi Kudo
37 [GO] 2022―Feb―22 SARS-CoV-2 Infection in the Follow-Up of a Population With Inflammatory Bowel Disease Rodrigo Quera, Paulina Núñez F, Lilian Flores
38 [GO] 2022―Jan―22 COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE Emily Spiera, Danielle Ganjian, Xian Zhang, Erica Brenner, Manasi Agrawal, Jean-Frederic Colombel, et al. (+3)
39 [GO] 2022―Jan―22 EFFECTS OF DELAYED ENDOSCOPIES IN INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC Karen Young, Devesh Hargunani, Vitaliy Poylin
40 [GO] 2022―Jan―22 ACUITY OF PEDIATRIC INFLAMMATORY BOWEL DISEASE ADMISSIONS PRE AND DURING THE COVID-19 PANDEMIC Malika Waschmann, Ariana Stuart, Henry Lin, Anna Hunter
41 [GO] 2022―Jan―22 FEAR OF THE COVID-19 PANDEMIC IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE: RELATIONSHIP TO PSYCHOLOGICAL AND PHYSICAL OUTCOMES Nicole Neiman, Kavya Anjur, Ann Ming Yeh, Rachel Bensen, Anava Wren
42 [GO] 2022―Jan―22 EVALUATING THE IMPACT OF THE COVID-19 PANDEMIC ON URGENT MEDICAL ACCESS FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE AT A PRIVATE COMMUNITY GASTROENTEROLOGY PRACTICE Michelle Kwon, Chung Sang Tse, Welmoed van Deen, Michael Danielewicz, Christopher Ward, Lawrence Kogan, et al. (+2)
43 [GO] 2022―Jan―22 SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE Muhammad Khan, Kamran Mushtaq, Muhammad Saddique, Mohd Alghizzawi, Muhammad Yasir, Hafiz Younis, et al. (+5)
44 [GO] 2022―Jan―22 SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY Joshua Quan, Christopher Ma, Remo Panaccione, Jamil Kanji, Graham Tipples, Nastaran Sharifi, et al. (+18)
45 [GO] 2022―Jan―15 The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis Gilaad G Kaplan, Fox E Underwood, Stephanie Coward, Manasi Agrawal, Ryan C Ungaro, Erica J Brenner, et al. (+11)
46 [GO] 2021―Dec―18 Inflammatory Bowel Disease Triggered by BNT162b2 mRNA Vaccination for SARS-CoV-2 Yosuke Shimodaira, Kenta Watanabe, So Takahashi, Shigeto Koizumi, Katsunori Iijima
47 [GO] 2021―Dec―06 Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID Kimberly N Weaver, Xian Zhang, Xiangfeng Dai, Runa Watkins, Jeremy Adler, Marla C Dubinsky, et al. (+13)
48 [GO] 2021―Dec―01 COVID-19 as a Trigger for De Novo Crohn’s Disease Antonio Tursi, Rosanna Nenna
49 [GO] 2021―Dec―01 Mesalazine in Inflammatory Bowel Disease and COVID-19: Hospitalization and Adverse In-Hospital Outcomes Based on Nationwide Data Simon Kjeldsen, Jan Nielsen, Bente Mertz Nørgård, Jens Kjeldsen
50 [GO] 2021―Dec―01 Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice David M Alvarado, Juhee Son, Larissa B Thackray, Maria Florencia Gomez Castro, Sarada Prasad, Xueyang Cui, et al. (+4)
51 [GO] 2021―Nov―18 Letter of Reply to “Response to: COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients’ Association” Andrea Costantino, Daniele Noviello, Claudio Costantino, Maurizio Vecchi, Flavio Caprioli
52 [GO] 2021―Oct―31 COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis Kartikeya Tripathi, Gala Godoy Brewer, Minh Thu Nguyen, Yuvaraj Singh, Mohamed Saleh Ismail, Jenny S Sauk, et al. (+2)
53 [GO] 2021―Sep―24 Addressing COVID-19 Vaccine Hesitancy in Patients with IBD Dania Hudhud, Freddy Caldera, Raymond K Cross
54 [GO] 2021―Sep―16 Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease Joelynn Dailey, Lina Kozhaya, Mikail Dogan, Dena Hopkins, Blaine Lapin, Katherine Herbst, et al. (+8)
55 [GO] 2021―Aug―24 Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients Elizabeth A Spencer, Eyal Klang, Michael Dolinger, Nanci Pittman, Marla C Dubinsky
56 [GO] 2021―Aug―23 Potential Value of Electroacupuncture in the Treatment of Gastrointestinal Symptoms of COVID-19 Xianqiang Yu
57 [GO] 2021―Jul―28 New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International Registry Ryan C Ungaro, Manasi Agrawal, Erica J Brenner, Xian Zhang, Jean-Frederic Colombel, Michael D Kappelman, Walter Reinisch
58 [GO] 2021―Jul―14 COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients’ Association Andrea Costantino, Daniele Noviello, Francesco Simone Conforti, Marina Aloi, Alessandro Armuzzi, Fabrizio Bossa, et al. (+12)
59 [GO] 2021―Jun―28 SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire Jens Walldorf, Ulrike von Arnim, Renate Schmelz, Anica Riesner-Wehner, Patrick Michl, Philip C Grunert, et al. (+3)
60 [GO] 2021―Jun―05 Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey Federica Crispino, Daniele Brinch, Lucio Carrozza, Maria Cappello
61 [GO] 2021―May―20 Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD Freddy Caldera, Sophie Balzora, Mary S Hayney, Francis A Farraye, Raymond K Cross
62 [GO] 2021―May―17 COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies Jacqueline D Squire, Alexei Gonzalez-Estrada, Freddy Caldera, Francis A Farraye
63 [GO] 2021―May―14 Impact of COVID-19 on Inflammatory Bowel Disease Clinical Trial Recruitment: A Global Survey of Principal Investigators Vipul Jairath, Leonardo Guizzetti, K Adam Baker, Lee Anne Williamson, Rocio Sedano, Hershell Thompson, Christopher Ma
64 [GO] 2021―Apr―27 COVID-19 Hospitalizations Among U.S. Medicare Beneficiaries With Inflammatory Bowel Disease, April 1 to July 31, 2020 Fang Xu, Susan A Carlson, Anne G Wheaton, Kurt J Greenlund
65 [GO] 2021―Mar―30 Safety of Tofacitinib in the COVID-19 Pandemic-Enough Is Not Enough Philipp A Reuken, Niels Teich, Andreas Stallmach
66 [GO] 2021―Mar―11 The Effect of COVID-19 Resurgence on Morbidity and Mortality in Patients With IBD on Biologic Therapy Srdjan Markovic, Tamara Knezevic Ivanovski, Branimir Zogovic, Ana Kalaba, Dusan Zaric, Petar Svorcan
67 [GO] 2021―Feb―22 Leukocytoclastic Vasculitis in Cutaneous Crohn Disease in the Setting of COVID-19 Najib Nassani, Nadera Sweiss, John Thomas Berry, Clarence Calhoun, Anne Polick, Itishree Trivedi
68 [GO] 2021―Feb―22 SARS-CoV-2 as a Trigger for De Novo Ulcerative Colitis Nicola Imperatore, Raffaele Bennato, Alfredo D’Avino, Giovanni Lombardi, Francesco Manguso
69 [GO] 2021―Feb―12 Time to Negative SARS-CoV-2 PCR Should Not Delay Care Among Patients With Inflammatory Bowel Diseases Rachel W Winter, Ashwin Ananthakrishnan, Kristin E Burke, Bharati Kochar, Walter W Chan, Jessica R Allegretti
70 [GO] 2021―Jan―29 Commenting on the Letter (Completing the Picture in Egypt: Response to “Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic”) Mohamed Eltabbakh, Waleed Abd Alaty, Mohamed Amin Sakr, Ahmed F Sherief
71 [GO] 2021―Jan―29 Completing the Picture in Egypt: Response to “Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic” Mohammed Khorshid, Mohamed AbdAllah
72 [GO] 2021―Jan―21 PATIENTS WITH INFLAMMATORY BOWEL DISEASE PERSPECTIVE ON COVID-19 AND HEALTH CARE SERVICE DURING THE PANDEMIC Randi Opheim, Kristian Moum, Bjørn Moum
73 [GO] 2021―Jan―21 A POPULATION-BASED APPROACH TO DIGITAL OUTREACH, TRIAGE, AND MONITORING OF IBD PATIENTS DURING THE COVID-19 PANDEMIC Ashish Atreja, Farah Fasihuddin, Shashank Garge, Liana Davidoff, Jonathan Rubin, Sarthak Kakkar, et al. (+6)
74 [GO] 2021―Jan―21 TELEMEDICINE IN IBD: GOOD TRUST FROM OUTPATIENTS DURING THE COVID-19 PANDEMIC IN MILAN (LOMBARDY) Andrea Costantino, Daniele Noviello, Stefano Mazza, Roberto Berté, Maurizio Vecchi, Flavio Caprioli
75 [GO] 2021―Jan―21 RISK OF ADVERSE OUTCOMES IN HOSPITALIZED PATIENTS WITH AUTOIMMUNE DISEASE AND COVID-19: A MATCHED COHORT STUDY FROM NEW YORK CITY Adam Faye, Kate Lee, Monika Laszkowska, Judith Kim, John Blackett, Anna McKenney, et al. (+8)
76 [GO] 2021―Jan―21 SARS-COV-2 INFECTION AND SEROCONVERSION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS Wenly Ruan, Faith Ihekweazu, Seema Walsh, Lina Karam, Allyson Wyatt, Huyen Nguyen, Richard Kellermayer
77 [GO] 2021―Jan―21 INCREASED CATHEPSIN EXPRESSION CORRELATES WITH SARS-COV-2 INFECTION IN HUMAN IBD ENTEROIDS David Alvarado, Maria Gomez Castro, Naomi Sonnek, Xueyang Cui, Siyuan Ding, Matthew Ciorba
78 [GO] 2020―Dec―16 Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry Manasi Agrawal, Erica J Brenner, Xian Zhang, Irene Modesto, John Woolcott, Ryan C Ungaro, et al. (+2)
79 [GO] 2020―Nov―30 Ileum Perforation in Crohn’s Disease Patient During SARS-Cov-2 Infection Genoile Oliveira Santana, Andréa Canário de Santana, Vanessa Barto Pfeilsticker
80 [GO] 2020―Oct―22 Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases Kristin E Burke, Bharati Kochar, Jessica R Allegretti, Rachel W Winter, Paul Lochhead, Hamed Khalili, et al. (+4)
81 [GO] 2020―Oct―16 Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease Mariana Ferreira-Duarte, Maria Manuela Estevinho, Margarida Duarte-Araújo, Fernando Magro, Manuela Morato
82 [GO] 2020―Oct―12 COVID-19 Pandemic’s Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research Inês A Trindade, Nuno B Ferreira
83 [GO] 2020―Oct―12 Biological Therapy for Inflammatory Bowel Disease During the COVID-19 Pandemic: Experiences From a Tertiary IBD Service Srdjan Markovic, Tamara Knezevic Ivanovski, Branimir Zogovic, Mirjana Cvetkovic, Petar Svorcan
84 [GO] 2020―Oct―12 SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn’s Disease Christina Dimopoulos, Badr Al-Bawardy
85 [GO] 2020―Oct―08 Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey Massimo Caludio Fantini, Livia Biancone, Gabriele Dragoni, Cristina Bezzio, Agnese Miranda, Davide Giuseppe Ribaldone, et al. (+40)
86 [GO] 2020―Sep―19 COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy Chiara Viganò, Sara Massironi, Lorena Pirola, Laura Cristoferi, Maria Fichera, Marianna Bravo, et al. (+4)
87 [GO] 2020―Sep―09 Establishing Safe Out-of-Hospital Infusion Centers May Improve the Quality of Care in Patients With IBD During the COVID-19 Pandemic Catherine Behzad, Hassan Taheri, Mehrdad Kashifard
88 [GO] 2020―Sep―03 Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic Asher Kornbluth, Michele Kissous-Hunt, James George, Peter Legnani
89 [GO] 2020―Sep―01 Biologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease Cristina Bezzio, Lucienne Pellegrini, Gianpiero Manes, Ilaria Arena, Desirée Picascia, Cristina Della Corte, et al. (+3)
90 [GO] 2020―Aug―31 Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic Mohamed Mahmoud Eltabbakh, Mostafa Abd Alfatah Shamkh, Ahmed Nagah Bassuny, Waleed Hamed Abd Alaty, Mohamed Amin Sakr, Ahmed Fouad Sherief
91 [GO] 2020―Aug―24 Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain Ivan Guerra, Alicia Algaba, Laura Jiménez, Mª Mar Aller, Daniel Garza, Daniel Bonillo, et al. (+2)
92 [GO] 2020―Aug―19 Management of Immune-Related Colitis During the COVID-19 Pandemic Rajan Amin, Anusha S Thomas, Shruti Khurana, Kavea Panneerselvam, Fangwen Zou, Weijie Ma, et al. (+2)
93 [GO] 2020―Aug―19 Innovation in IBD Care During the COVID-19 Pandemic: Results of a Cross-Sectional Survey on Patient-Reported Experience Measures Carlos Taxonera, Cristina Alba, David Olivares, María Martin, Alejandro Ventero, Mercedes Cañas
94 [GO] 2020―Aug―19 Ambulatory Management of Acute Severe Ulcerative Colitis: A Pandemic-driven Initiative Tristan Townsend, Joseph Fiske, Paul Collins, Ashley Bond, Alan Steel, Martyn Dibb, et al. (+2)
95 [GO] 2020―Aug―14 Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey Charles N Bernstein, Siew C Ng, Rupa Banerjee, Flavio Steinwurz, Bo Shen, Franck Carbonnel, et al. (+48)
96 [GO] 2020―Aug―01 Inflammatory Bowel Disease Management in a Major Referral Center During COVID-19 Pandemic Isabel Garrido, Susana Lopes, Guilherme Macedo
97 [GO] 2020―Aug―01 Management of IBD Patients Who Are Unwilling or Unable to Receive Infusion Therapy During the COVID-19 Pandemic Jamie M Horrigan, Corey A Siegel, Micheal Tadros
98 [GO] 2020―Jul―31 The Effect of the COVID-19 Pandemic on the Medical Mode of Patients With Inflammatory Bowel Disease in China Wen-ning Tian, Yu-hong Huang, Cong Dai
99 [GO] 2020―Jul―28 Italian IBD Patients Coping With Covid-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-care Greta Castellini, Mariarosaria Savarese, Salvatore Leone, Enrica Previtali, Alessandro Armuzzi, Guendalina Graffigna
100 [GO] 2020―Jul―28 Response to “Italian IBD Patients Coping With COVID-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-Care” Vincenzo Occhipinti, Orsola Raffaella Sociale, Luca Pastorelli
101 [GO] 2020―Jul―28 Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak Alessandro Rimondi, Gian Eugenio Tontini, Stefano Mazza, Flavio Caprioli, Angelo Sangiovanni, Pietro Lampertico, Maurizio Vecchi
102 [GO] 2020―Jul―28 The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications Franco Scaldaferri, Gianluca Ianiro, Giuseppe Privitera, Loris Riccardo Lopetuso, Lorenzo Maria Vetrone, Valentina Petito, et al. (+8)
103 [GO] 2020―Jul―17 Safety of Endoscopy in Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic Udayakumar Navaneethan, Dennisdhilak Lourdusamy, Vanessa LehnerNoguera, Bo Shen
104 [GO] 2020―Jul―06 A Challenging Colectomy for Acute Severe Ulcerative Colitis Complicated by COVID-19 Mirko Di Ruscio, Angela Variola, Andrea Angheben, Silvia Resimini, Andrea Geccherle, Giacomo Ruffo, Giuliano Barugola
105 [GO] 2020―Jul―03 The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis Muhammad Aziz, Rawish Fatima, Hossein Haghbin, Wade Lee-Smith, Ali Nawras
106 [GO] 2020―Jul―03 Reply to the Letter to the Editor: The Incidence and Outcomes of COVID-19 in Patients With IBD: A Rapid Review and Meta-Analysis Juan F Burgueño, Maria T Abreu
107 [GO] 2020―Jul―03 Should We Be Screening for SARS-CoV-2 in IBD Patients Before Initiation of Biologic Therapy? Jana G Hashash, Suha Jabak, Fadi F Francis, Miguel Regueiro
108 [GO] 2020―Jul―03 Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic Laurie B Grossberg, Randall S Pellish, Adam S Cheifetz, Joseph D Feuerstein
109 [GO] 2020―Jun―27 Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective Jennie N Clough, Katie L Hill, Alexa Duff, Esha Sharma, Shuvra Ray, Joel E Mawdsley, et al. (+3)
110 [GO] 2020―Jun―24 From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area Jordan E Axelrad, Lisa Malter, Simon Hong, Shannon Chang, Brian Bosworth, David Hudesman
111 [GO] 2020―Jun―24 Prolonged Duration of SARS-CoV-2 Viral Positivity in a Crohn’s Disease Patient Udayakumar Navaneethan, Vanessa LehnerNoguera
112 [GO] 2020―Jun―12 Inflammatory Bowel Disease and COVID-19-“Preventive” Sick Certificates as a Frequent Coping Strategy in the Face of the Pandemic Franziska Schlabitz, Niels Teich, Patrick Michl, Jens Walldorf
113 [GO] 2020―Jun―04 Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey Eduardo Martin Arranz, Cristina Suarez Ferrer, Laura García Ramírez, Jose Luis Rueda García, María Sánchez-Azofra, Joaquín Poza Cordón, et al. (+4)
114 [GO] 2020―Jun―01 The Greek Response to COVID-19: A True Success Story from an IBD Perspective Giorgos Bamias, Styliani Lagou, Michalis Gizis, George Karampekos, Konstantinos G Kyriakoulis, Christos Pontas, Gerassimos J Mantzaris
115 [GO] 2020―May―25 IBD in the Times of COVID-19 Stefany Hernández Benabe, Amber H Langshaw
116 [GO] 2020―May―22 Clinical and Psychological Issues in Children with Inflammatory Bowel Disease During COVID-19 Pandemic Massimo Martinelli, Caterina Strisciuglio, Flora Fedele, Erasmo Miele, Annamaria Staiano
117 [GO] 2020―May―22 Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2 Mehmet Bostancıklıoğlu
118 [GO] 2020―May―12 Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature Melissa H Rosen, Jordan Axelrad, David Hudesman, David T Rubin, Shannon Chang
119 [GO] 2020―May―09 Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not? Roberto Grassia, Sara Soro, Clara Benedetta Conti
120 [GO] 2020―May―08 Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19 Antonio Tursi, Lorenzo Maria Vetrone, Alfredo Papa
121 [GO] 2020―Apr―28 Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib Jeffrey Jacobs, Kindra Clark-Snustad, Scott Lee
122 [GO] 2020―Apr―25 Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD Juan F Burgueño, Adrian Reich, Hajar Hazime, Maria A Quintero, Fernandez Irina, Julia Fritsch, et al. (+11)
123 [GO] 2020―Apr―21 Challenges in the Care of IBD Patients During the CoViD-19 Pandemic: Report From a “Red Zone” Area in Northern Italy Vincenzo Occhipinti, Luca Pastorelli
 [1] 

123 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec